Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-15

Clinical Trial Update: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the impact of alfuzosin on sexuality and management of benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alfuzosin (alfuzosin)

Snippet

Sponsor: Sanofi | Conditions: Prostatic Hyperplasia | Phase 4 | Status: COMPLETED